一个先进的多焦点胆瘤病例,对Pembrolizumab有很好的反应
Tehmina Habib1, Mohammad Abu-Abaa1, Neel Gandhi1
1Internal Medicine, Capital Health Regional Medical Center, Trenton, USA.
Cureus
|June 2, 2023
概括
免疫检查点抑制剂 (ICI) 在治疗晚期胆道癌症方面表现有前途. 一名患有不可切割的胆管癌的患者,在用 pembrolizumab 单一治疗后,实现了持续的三年缓解.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 先进的胆道恶性瘤,包括胆管癌 (CCA),具有有限的治疗选择.
- 免疫检查点抑制剂 (ICI) 正成为一个有前途的治疗策略.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
514
相关概念视频
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
01:27Tumor Immunotherapy
577
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
577